Riskpilot← Back to searchSign inGet full accessLaqua Treatment AB
ABActiveOrg 5563018844Siriusvägen 16Wholesale of other machinery and equipment · NACE 4664Est. 19870 employees
Revenue 2025
SEK 1,6M
-24% vs 2024
EBITDA margin
21.1%
-16% vs 2024
Equity ratio
45.5%
Financial strength
Net profit 2025
SEK 300K
0% vs 2024
| Revenue | SEK 1,6M | -24% |
| EBITDA | SEK 348K | -16% |
| Net profit | SEK 300K | +0% |
| Total assets | SEK 2,3M | -4% |
| Equity | SEK 1M | +11% |
| Employees | 0 | — |
Legal name
Laqua Treatment AB
Org number
5563018844
Legal form
Aktiebolag
NACE code
4664 · Wholesale of other machinery and equipment
Founded
9 juli 1987
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva utveckling och försäljning av systemlösningar för återföring av organiska restprodukter, försäljning och underhåll av system för lokal rening av förorenat vatten, företagsrådgivning jämte därmed förenlig verksamhet.
Address
Siriusvägen 16
Email
dahn@laqua.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 691 | 1 734 | 2 851 | 2 176 | 1 649 |
| Staff expenses | — | — | — | — | −85 |
| EBITDA | 799 | 639 | 491 | 415 | 348 |
| Depreciation & amort. | −36 | −131 | −128 | −141 | −141 |
| EBIT | 763 | 508 | 363 | 274 | 207 |
| Net financials | −38 | −116 | −80 | 59 | 17 |
| Profit before tax | 442 | 509 | 303 | 392 | 401 |
| Tax | −98 | −120 | −55 | −92 | −101 |
| Net profit | 344 | 389 | 248 | 300 | 300 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 216 | 2 756 | 3 054 | 2 380 | 2 287 |
| Equity | 1 104 | 1 093 | 941 | 941 | 1 041 |
| Long-term debt | 1 000 | 617 | 1 017 | 517 | 262 |
| Short-term debt | 244 | 250 | 312 | 198 | 438 |
| Total debt | 1 244 | 867 | 1 329 | 715 | 700 |
EBITDA margin
21.1%
This company
15.8%
Market median
+34% vs market
20212025
Equity ratio
45.5%
This company
38.2%
Market median
+19% vs market
20212025
Return on equity
28.8%
This company
18.4%
Market median
+57% vs market
20212025
Net profit margin
18.2%
This company
8.1%
Market median
+125% vs market
20212025
Asset turnover
0.72×
This company
1.12×
Market median
-36% vs market
20212025
Debt / equity
1.20×
This company
0.62×
Market median
-94% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
PO Auditor Substitute | Auditor Substitute | 2022 |
SA Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Laqua Treatment AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Olof Tillström | Auditor Substitute | 0 companies |
| Sven Anders Isaksson | Audit | 0 companies |
| Bror Dahn Inge Rosenquist | Board of Directors | 0 companies |
| Eva Lena Rosenquist | Deputy Board Member | 0 companies |